Dr Richard Lee, Integration of Blood Biomarkers (WP7)
Dr Richard Lee is the clinical lead for blood biomarker research within the DART AI programme.
Dr Richard Lee is a Consultant Physician in Respiratory Medicine and Champion for Early Cancer Diagnosis at the Royal Marsden Hospital. He has a clinical interest in respiratory medicine and early diagnosis of lung cancer.
He studied undergraduate medical sciences at Sidney Sussex College, University of Cambridge, and completed his medical training at Guy’s, King’s and St Thomas’s medical school in 2005. He undertook respiratory medicine training in the South Thames region, rotating through Guy’s, St Thomas’s and King’s College Hospitals. He was awarded a PhD in lung cancer by Kings College London, for study of EGFR TKI resistance in lung adenocarcinoma and its relevance for MET targeted therapy, which was funded by prestigious NIHR and MRC Clinical Research Training Fellowships and for which he received a British Thoracic Society Young Investigator award. During this time he completed a post-graduate certificate in education at the King’s Learning institute and continues to contribute to teaching trainee doctors for post-graduate examinations.
Dr Lee has a research interest in Early diagnosis of all cancer types with a focus on lung cancer. He leads on biomarker development for the RM Partners Low-Dose CT Lung cancer case-finding study and has a research portfolio that includes translation of artificial intelligence research to early cancer detection and screening. Dr Lee also has an interest in using data science to improve lung cancer care and research using informatics based approaches and has previously developed a Smart-Phone app for respiratory trainees.
Dr Lee leads on Early Diagnosis strategy at the Royal Marsden, which is developing innovative clinical services to ensure that the Royal Marsden is an international thought-leader in early diagnosis and contributes actively to NHS England’s 2028 ambition to diagnose 75% of all cancers at an early stage. His work in this area is funded by the Royal Marsden Cancer Charity with whom Dr Lee continues to work closely to promote the importance of early cancer diagnosis amongst patients and colleagues.
Dr Lee is also the lung pathway chair at the Royal Marsden Partners Cancer Alliance (North and South West London) and Joint Clinical Lead for the NHS England National Targeted Lung Health Check pilot. He serves on the British Thoracic Society Lung Cancer Committee, the NIHR Health Informatics Collaborative for lung cancer and The European Respiratory Society’s college of experts. He has also contributed to the development of Rapid Diagnosis Centres with NHS England.
Dr Lee leads Work Package 7 Integration of Blood Biomarkers.